ASHG 2026 has ended. This guide stays up as the record of who was there. Next: ASHG 2027, Oct 26–30, 2027 in Nashville
Université de Sherbrooke at ASHG 2026
Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website
Université de Sherbrooke brings 7 presentations from 4 research groups to ASHG 2026 in Montréal. Its program at this meeting centres on rare diseases, genomic screening, and genetics-guided treatment. Équipe du Pr Bouchard expands carrier screening across three Québec regions, Choquet Lab decodes COL6A1-3 splicing in muscular dystrophies, and Laboratoire de recherche et transfert en pharmacogénétique (LRTP) investigates variants for advanced ulcerative colitis therapies.
| Organization | ASHG 2026 Attendance |
|---|---|
Université de Sherbrooke Sherbrooke, Quebec | 5 PhD Students |
Équipe du Pr Bouchardchairegps.com Studies blood microRNAs, 850,000-site DNA-methylation arrays and genetic carrier-screening samples. Projects target gestational diabetes, childhood obesity and rare founder-effect diseases in Québec populations.
| Poster Wed Oct 21 2:30 pm Microtranscriptomic response to oral glucose load in parous women with and without prior history of gestational diabetes DiabetesEpigeneticsMicroRNAWomen's health Poster Wed Oct 21 2:30 pm Expansion of the provincial carrier screening program for populations from Saguenay-Lac-Saint-Jean, Charlevoix, and Haute-Côte-Nord Regions (Québec, Canada) Rare variantsGenetic testingPublic healthClinical genetics |
Choquet Labchoquetlab.com Studies RNA maturation using nanopore direct RNA sequencing, functional genomics, molecular biology and bioinformatics. Focuses on long-transcript splicing, cell differentiation and human disease.
| Poster Wed Oct 21 2:30 pm Decoding the Splicing Order of COL6A1-3: A Key to Understanding Collagen VI-Related Muscular Dystrophies Alternative splicingSplicing mechanismsGenetic variationMuscular abnormalities |
Laboratoire de recherche et transfert en pharmacogénétique (LRTP)lrtp.ca Develops genetic tests from biological samples using digital PCR. Studies medication response in inflammatory bowel disease, diabetes and MODY2.
| Poster Thu Oct 22 4:15 pm Pharmacogenetic variants investigation for advanced therapies in ulcerative colitis treatment PharmacogenomicsCandidate geneGastrointestinal systemMolecular therapeutics |
Équipe de recherche sur les pratiques professionnelles optimales en soins primaires (PPOSP)en.poitraslab.com/equipederecherche Studies patient-reported data (PREMs and PROMs) and MODY2 genetic-testing implementation in primary care. Improves patient-centered practices through knowledge transfer and Canadian research partnerships.
| Poster Wed Oct 21 2:30 pm Evaluation of the Implementation of Genetic Testing for MODY2 Screening in Primary Care in the Saguenay–Lac-Saint-Jean Region: Pilot Phase of the iMOgene Project Genetic testingDiabetesDiagnosticsPrecision medicine |
| 2 more presenters — research group not yet identified | |
Find decision makers at Université de Sherbrooke
Tell us what you sell and we’ll find the people at Université de Sherbrooke most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction